Role of endothelial microRNA 155 on capillary leakage in systemic inflammation

Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endo...

Full description

Saved in:
Bibliographic Details
Published inCritical care (London, England) Vol. 25; no. 1; pp. 76 - 12
Main Authors Etzrodt, Valerie, Idowu, Temitayo O., Schenk, Heiko, Seeliger, Benjamin, Prasse, Antje, Thamm, Kristina, Pape, Thorben, Müller-Deile, Janina, van Meurs, Matijs, Thum, Thomas, Garg, Ankita, Geffers, Robert, Stahl, Klaus, Parikh, Samir M., Haller, Hermann, David, Sascha
Format Journal Article
LanguageEnglish
Published London BioMed Central 22.02.2021
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1364-8535
1466-609X
1364-8535
1466-609X
1366-609X
DOI10.1186/s13054-021-03500-0

Cover

Abstract Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. Methods SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Results Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. Conclusions We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.
AbstractList Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.
Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 x upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.
Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. Methods SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Results Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 x upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. Conclusions We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target. Keywords: Tight junctions, Respiratory distress syndrome, MicroRNAs, Endothelium, Sepsis
Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage.BACKGROUNDCapillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage.SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance.METHODSSmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance.Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects.RESULTSEndothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects.We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.CONCLUSIONSWe found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.
Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. Methods SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Results Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. Conclusions We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.
Abstract Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. Methods SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Results Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. Conclusions We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.
Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. Methods SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Results Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. Conclusions We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.
ArticleNumber 76
Audience Academic
Author Thum, Thomas
Idowu, Temitayo O.
Geffers, Robert
Garg, Ankita
Etzrodt, Valerie
Haller, Hermann
van Meurs, Matijs
David, Sascha
Prasse, Antje
Parikh, Samir M.
Schenk, Heiko
Müller-Deile, Janina
Seeliger, Benjamin
Stahl, Klaus
Pape, Thorben
Thamm, Kristina
Author_xml – sequence: 1
  givenname: Valerie
  orcidid: 0000-0002-9493-5346
  surname: Etzrodt
  fullname: Etzrodt, Valerie
  organization: Division of Nephrology and Hypertension, Hannover Medical School
– sequence: 2
  givenname: Temitayo O.
  surname: Idowu
  fullname: Idowu, Temitayo O.
  organization: Division of Nephrology and Hypertension, Hannover Medical School
– sequence: 3
  givenname: Heiko
  surname: Schenk
  fullname: Schenk, Heiko
  organization: Division of Nephrology and Hypertension, Hannover Medical School, Mount Desert Island Biological Laboratory
– sequence: 4
  givenname: Benjamin
  surname: Seeliger
  fullname: Seeliger, Benjamin
  organization: Department of Respiratory Medicine and German Center for Lung Research, Hannover Medical School
– sequence: 5
  givenname: Antje
  surname: Prasse
  fullname: Prasse, Antje
  organization: Department of Respiratory Medicine and German Center for Lung Research, Hannover Medical School
– sequence: 6
  givenname: Kristina
  surname: Thamm
  fullname: Thamm, Kristina
  organization: Division of Nephrology and Hypertension, Hannover Medical School
– sequence: 7
  givenname: Thorben
  surname: Pape
  fullname: Pape, Thorben
  organization: Division of Nephrology and Hypertension, Hannover Medical School
– sequence: 8
  givenname: Janina
  surname: Müller-Deile
  fullname: Müller-Deile, Janina
  organization: Division of Nephrology and Hypertension, University Hospital Erlangen
– sequence: 9
  givenname: Matijs
  surname: van Meurs
  fullname: van Meurs, Matijs
  organization: Department of Critical Care, University of Groningen, University Medical Center Groningen
– sequence: 10
  givenname: Thomas
  surname: Thum
  fullname: Thum, Thomas
  organization: Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School
– sequence: 11
  givenname: Ankita
  surname: Garg
  fullname: Garg, Ankita
  organization: Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School
– sequence: 12
  givenname: Robert
  surname: Geffers
  fullname: Geffers, Robert
  organization: Helmholtz Centre for Infection Research Brunswick
– sequence: 13
  givenname: Klaus
  surname: Stahl
  fullname: Stahl, Klaus
  organization: Division of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School
– sequence: 14
  givenname: Samir M.
  surname: Parikh
  fullname: Parikh, Samir M.
  organization: Center for Vascular Biology Research, Beth Israel Deaconess Medical Center and Harvard Medical School
– sequence: 15
  givenname: Hermann
  surname: Haller
  fullname: Haller, Hermann
  organization: Division of Nephrology and Hypertension, Hannover Medical School, Mount Desert Island Biological Laboratory
– sequence: 16
  givenname: Sascha
  surname: David
  fullname: David, Sascha
  email: david.sascha@mh-hannover.de, sascha.david@usz.ch
  organization: Division of Nephrology and Hypertension, Hannover Medical School, Institute of Intensive Care Medicine, University Hospital Zurich
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33618730$$D View this record in MEDLINE/PubMed
BookMark eNp9UstqHDEQHIJD_Eh-IIcwkEsu4-gx0mguAWPyMBgHTHIWkqa11kYjbUazAf99encd22uC0UGiVVWtLtVxdZBygqp6S8kppUp-LJQT0TaE0YZwQUhDXlRHlMu2UYKLg0fnw-q4lCUhtFOSv6oOOZdUdZwcVVfXOUKdfQ1pyPMNxGBiPQY35eurs5oKUedUO7MKMZrpto5gfpkF1CHV5bbMgEg8-2jG0cwhp9fVS29igTd3-0n188vnH-ffmsvvXy_Ozy4bJ0k3N1IoprpWMEEYc4xZJ7nBmpDcW-_xWjLOZMdhAMkHapjiA7jeWmBW9Z6fVBc73SGbpV5NYcTX6WyC3hbytNBmmoOLoK0nXlhvlZWy5ZxYK4H2TAAB46lgqPVpp7Va2xEGB2meTNwT3b9J4UYv8h_d9YQSRVHgw53AlH-vocx6DMUBOpYgr4tmbc-kJKyVCH3_BLrM6ymhVXrjhegVpewBtTA4APqbsa_biOozKbgUjHYCUaf_QeEaNt-CUfEB63uEd48HvZ_wXxoQwHYA_P5SJvD3EEr0JnJ6FzmNkdPbyOkNST0huTBvw4DPCfF5Kt9RC_ZJC5ge3HiG9RfDNucw
CitedBy_id crossref_primary_10_1016_j_phrs_2022_106509
crossref_primary_10_3390_ijms24032582
crossref_primary_10_2147_JIR_S504184
crossref_primary_10_1038_s41598_024_81114_6
crossref_primary_10_3389_fendo_2023_1237866
crossref_primary_10_3390_jpm14030225
crossref_primary_10_1007_s10753_022_01708_y
crossref_primary_10_1186_s12871_022_01947_4
crossref_primary_10_3389_fimmu_2022_951798
Cites_doi 10.1038/sj.jid.5700865
10.1016/j.micinf.2005.12.016
10.1056/NEJMra1208623
10.3390/ijms17010078
10.1093/bioinformatics/btt656
10.1371/journal.pone.0179850
10.1001/jama.2016.0287
10.1161/JAHA.118.009244
10.1097/CCM.0000000000003269
10.1093/toxsci/46.2.300
10.7754/Clin.Lab.2016.160511
10.1186/s40635-018-0203-4
10.1097/CCM.0000000000000524
10.1161/ATVBAHA.111.233189
10.1093/bioinformatics/btp616
10.1155/2019/6714080
10.1097/SHK.0000000000001243
10.1165/rcmb.2011-0289OC
10.1093/bioinformatics/bts635
10.1007/s00441-017-2593-0
10.1186/cc13806
10.3389/fimmu.2018.00057
10.1155/2013/658270
10.1097/CCM.0b013e31825fdc31
10.1016/S0092-8674(04)00045-5
ContentType Journal Article
Copyright The Author(s) 2021
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13054-021-03500-0
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed


MEDLINE - Academic
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1364-8535
1466-609X
1366-609X
EndPage 12
ExternalDocumentID oai_doaj_org_article_bf0f5bfb8b664330bb6e1925e0eaf152
PMC7901081
A653652175
33618730
10_1186_s13054_021_03500_0
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom
Germany
GeographicLocations_xml – name: United Kingdom
– name: Germany
GrantInformation_xml – fundername: Medizinische Hochschule Hannover (MHH) (3118)
– fundername: Deutsche Forschungsgemeinschaft
  grantid: DA 1209/4-3; ME 3696/3-1; ME 3696/3-1
  funderid: http://dx.doi.org/10.13039/501100001659
– fundername: Deutsche Zentrum für Lungenforschung
  funderid: http://dx.doi.org/10.13039/501100010564
– fundername: Deutsche Forschungsgemeinschaft
  grantid: ME 3696/3-1
– fundername: Deutsche Forschungsgemeinschaft
  grantid: DA 1209/4-3
– fundername: ;
– fundername: ;
  grantid: DA 1209/4-3; ME 3696/3-1; ME 3696/3-1
GroupedDBID ---
0R~
29F
2WC
4.4
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
OK1
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
ROL
RPM
RSV
SJN
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
YOC
AAYXX
ALIPV
CITATION
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c607t-6582874525022c22bc63a582563fbff6586232673ede63d1a283dec9bbe2b89f3
IEDL.DBID U2A
ISSN 1364-8535
1466-609X
IngestDate Wed Aug 27 01:21:47 EDT 2025
Thu Aug 21 14:25:34 EDT 2025
Thu Sep 04 18:06:37 EDT 2025
Sun Sep 07 03:34:11 EDT 2025
Tue Jun 17 21:27:18 EDT 2025
Tue Jun 10 20:37:23 EDT 2025
Thu Apr 03 07:05:44 EDT 2025
Thu Apr 24 23:12:02 EDT 2025
Tue Jul 01 03:55:00 EDT 2025
Sat Sep 06 07:24:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Sepsis
Tight junctions
Respiratory distress syndrome
MicroRNAs
Endothelium
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-6582874525022c22bc63a582563fbff6586232673ede63d1a283dec9bbe2b89f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9493-5346
OpenAccessLink https://link.springer.com/10.1186/s13054-021-03500-0
PMID 33618730
PQID 2502598112
PQPubID 44362
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_bf0f5bfb8b664330bb6e1925e0eaf152
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7901081
proquest_miscellaneous_2492660246
proquest_journals_2502598112
gale_infotracmisc_A653652175
gale_infotracacademiconefile_A653652175
pubmed_primary_33618730
crossref_primary_10_1186_s13054_021_03500_0
crossref_citationtrail_10_1186_s13054_021_03500_0
springer_journals_10_1186_s13054_021_03500_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-22
PublicationDateYYYYMMDD 2021-02-22
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-22
  day: 22
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Critical care (London, England)
PublicationTitleAbbrev Crit Care
PublicationTitleAlternate Crit Care
PublicationYear 2021
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References F Benz (3500_CR20) 2016; 17
H Schenk (3500_CR13) 2017; 369
C Johnston (3500_CR24) 1998; 46
MD Robinson (3500_CR10) 2010; 26
CM Robertson (3500_CR3) 2006; 8
Y Liao (3500_CR9) 2014; 30
S David (3500_CR25) 2012; 40
A Aslan (3500_CR15) 2014; 18
B Zingarelli (3500_CR17) 2019; 51
F Tacke (3500_CR26) 2019; 2019
D Vermette (3500_CR5) 2018; 6
DC Angus (3500_CR2) 2013; 369
A Dobin (3500_CR8) 2013; 29
MH Wong (3500_CR23) 2012; 46
K Thamm (3500_CR12) 2018; 46
DP Bartel (3500_CR6) 2004; 116
JC Pena-Philippides (3500_CR22) 2018; 7
KL Hippen (3500_CR19) 2018; 9
Y Han (3500_CR21) 2016; 62
M Singer (3500_CR1) 2016; 315
T Stiehl (3500_CR11) 2014; 42
3500_CR7
CM Niessen (3500_CR4) 2007; 127
S David (3500_CR14) 2011; 31
N Hanke (3500_CR16) 2013; 2013
D Pfeiffer (3500_CR18) 2017; 12
References_xml – volume: 127
  start-page: 2525
  year: 2007
  ident: 3500_CR4
  publication-title: J Investig Dermatol
  doi: 10.1038/sj.jid.5700865
– volume: 8
  start-page: 1382
  year: 2006
  ident: 3500_CR3
  publication-title: Microbes Infect
  doi: 10.1016/j.micinf.2005.12.016
– volume: 369
  start-page: 840
  year: 2013
  ident: 3500_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1208623
– volume: 17
  start-page: 78
  year: 2016
  ident: 3500_CR20
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms17010078
– volume: 30
  start-page: 923
  year: 2014
  ident: 3500_CR9
  publication-title: Bioinformatics (Oxford, England)
  doi: 10.1093/bioinformatics/btt656
– volume: 12
  start-page: e0179850
  year: 2017
  ident: 3500_CR18
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0179850
– volume: 315
  start-page: 801
  year: 2016
  ident: 3500_CR1
  publication-title: JAMA
  doi: 10.1001/jama.2016.0287
– volume: 7
  start-page: 13
  year: 2018
  ident: 3500_CR22
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.118.009244
– volume: 46
  start-page: e928
  year: 2018
  ident: 3500_CR12
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000003269
– volume: 46
  start-page: 300
  year: 1998
  ident: 3500_CR24
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/46.2.300
– volume: 62
  start-page: 2355
  year: 2016
  ident: 3500_CR21
  publication-title: Clin Lab
  doi: 10.7754/Clin.Lab.2016.160511
– volume: 6
  start-page: 37
  year: 2018
  ident: 3500_CR5
  publication-title: Intensive Care Med Exp
  doi: 10.1186/s40635-018-0203-4
– volume: 42
  start-page: e654
  year: 2014
  ident: 3500_CR11
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000000524
– volume: 31
  start-page: 2643
  year: 2011
  ident: 3500_CR14
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.111.233189
– volume: 26
  start-page: 139
  year: 2010
  ident: 3500_CR10
  publication-title: Bioinformatics (Oxford, England)
  doi: 10.1093/bioinformatics/btp616
– volume: 2019
  start-page: 6714080
  year: 2019
  ident: 3500_CR26
  publication-title: Mediators Inflamm
  doi: 10.1155/2019/6714080
– volume: 51
  start-page: 10
  year: 2019
  ident: 3500_CR17
  publication-title: SHOCK
  doi: 10.1097/SHK.0000000000001243
– volume: 46
  start-page: 641
  year: 2012
  ident: 3500_CR23
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2011-0289OC
– volume: 29
  start-page: 15
  year: 2013
  ident: 3500_CR8
  publication-title: Bioinformatics (Oxford, England)
  doi: 10.1093/bioinformatics/bts635
– volume: 369
  start-page: 127
  year: 2017
  ident: 3500_CR13
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-017-2593-0
– volume: 18
  start-page: 423
  year: 2014
  ident: 3500_CR15
  publication-title: Crit Care (London, England)
  doi: 10.1186/cc13806
– volume: 9
  start-page: 57
  year: 2018
  ident: 3500_CR19
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.00057
– volume: 2013
  start-page: 1
  year: 2013
  ident: 3500_CR16
  publication-title: Biomed Res Int
  doi: 10.1155/2013/658270
– volume: 40
  start-page: 3034
  year: 2012
  ident: 3500_CR25
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e31825fdc31
– volume: 116
  start-page: 281
  year: 2004
  ident: 3500_CR6
  publication-title: Cell
  doi: 10.1016/S0092-8674(04)00045-5
– ident: 3500_CR7
SSID ssj0017863
Score 2.3966613
Snippet Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood,...
Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role...
Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood,...
Abstract Background Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 76
SubjectTerms Animal models in research
Antibodies
Biopsy
Critical care
Critical Care Medicine
Emergency Medicine
Endothelium
Health aspects
Inflammation
Intensive
Kidneys
Laboratory animals
Laparotomy
Lavage
Manufacturers
Medical research
Medicine
Medicine & Public Health
MicroRNA
MicroRNAs
Permeability
Properties
Proteins
Reagents
Respiratory distress syndrome
Sepsis
Tight junctions
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHhAXxJuUgoyExAGsOvbaSY4LoqqQuoeKSr1ZtmOLFUtStdsD_54ZJ1maIuDCLYodxf48L8sznwHe6MxaVwW-QPfAaf_FvWsVV9ELI5tS17nK9WRljs8Wn8_1-Y2rvignbKAHHoA79Ekk7ZOvvUHnqYT3JmJUoqOILqHzIesrGjFtpsbzgwp_MZXI1ObwCi21XnBKR6CTNMHFzA1ltv7fbfINp3Q7YfLWqWl2RkcP4P4YRbLlMPqHcCd2j-DuyXhO_hhWp_0msj6x2LVUYrVBKWPfKffudLVk6NxZ37HgLujKocsfbBPdN7QrbN2xgdl5HfA5obAMhY1P4Ozo05ePx3y8OYEHBH7LjR547DG-kTJI6YNRDt9po5JPCZsx6pGmUrGNRrWlwyCjjaHxPkpfN0k9hb2u7-JzYKKKjWhd6XSqFyFIvzBBldo5dO5RVlUB5QSkDSOtON1usbF5e1EbO4BvEXybwbeigHe7by4GUo2_9v5A67PrSYTY-QWKiR3FxP5LTAp4S6trSW1xeMGN1Qc4SSLAskujlcFQptIFHMx6orqFefMkH3ZU9ytLOOumxti1gNe7ZvqSUti62F9jH6JmNIiaKeDZIE67KSllyhptbQHVTNBmc563dOuvmQy8ovyauizg_SSSv4b1Z0z3_wemL-CezColuZQHsLe9vI4vMUTb-ldZG38CoI4y0w
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9JYLgg4Zrk-Zjn2QVj0O4fTg82LeQpIkut7br7t6D_72TNO3ZE--tNCk0k8nML8nMbxB6yxNrnXSkBvdA4v6LWNMwwrwtBZ1VXKUs19OFODmvvy75Mh-47XJY5WATk6FuOhfPyI_AVQNSVwAPPm5-kVg1Kt6u5hIat9GdRF0G-iyX44arkipVUquYqAm4JT4kzShxtAPbzWsSAxTi3VpJyoljSvz9_1rpv9zU9RDKa_eoyT0dP0D3M67E814RHqJbvn2E7p7mm_PHaHHWrT3uAvZtE5Ou1qB3-GeMxjtbzDG4e9y12JlNLEK0_Y3X3lyApcGrFvdczysHzwHUp091fILOj798-3xCci0F4mAq9kTwntk-ipE6Sq0TzMA7LliwIUAz4CAqJPONF6ypDMCOxruZtZ5aNQvsKTpou9Y_R7iUflY2pjI8qNo5amvhWMWNAXfvqZQFqgZBapeJxmO9i7VOGw4ldC98DcLXSfi6LND78ZtNT7NxY-9PcX7GnpEiO73ott91XnHahjJwG6yyAlAXK60VHuAs96U3AVBLgd7F2dVxIcPvOZPzEWCQkRJLzwVnAsCN5AU6nPSEBeimzYN-6GwAdvpKXQv0ZmyOX8agttZ3l9AnkjUKkJoo0LNencYhMSYqBda3QHKiaJMxT1va1Y9EDy5jxI2qCvRhUMmr3_q_TF_cPIqX6B5Ni4USSg_RwX576V8BHNvb12nN_QF2NStk
  priority: 102
  providerName: ProQuest
Title Role of endothelial microRNA 155 on capillary leakage in systemic inflammation
URI https://link.springer.com/article/10.1186/s13054-021-03500-0
https://www.ncbi.nlm.nih.gov/pubmed/33618730
https://www.proquest.com/docview/2502598112
https://www.proquest.com/docview/2492660246
https://pubmed.ncbi.nlm.nih.gov/PMC7901081
https://doaj.org/article/bf0f5bfb8b664330bb6e1925e0eaf152
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_0DsQX8dvquUQQfNBimzRJ93F3ueMQbpHFhcWXkKSJt7i2x-7eg_-9k7Rd7fkBvpRtk5RmMl_ZmfkF4DWPqHXSpgWahzTsv1KjK5YyZzJBxzkvY5XrxVycL4sPK77qisJ2fbZ7H5KMmjqKdSne71Db8iINKQUhGpaluFE_5rh3D-K4pJND7EDi6_vymD-OG5igiNT_uz7-xSDdTJa8ETGNhujsPtzrPEgyaZf8Adxy9UO4c9HFyB_BfNFsHGk8cXUVyqs2yGHkW8i7W8wnBA07aWpi9VU4bmj7nWyc_oo6haxr0qI6ry3-9sgobVHjY1ienX6anafdqQmpRaLvU8FbDHv0bSi1lBormMZnXDBvvMdm9HiokMxVTrAq1-hgVM6OjXHUlGPPnsBR3dTuGZBMunFW6VxzXxbWUlMIy3KuNRp2R6VMIO8JqWwHKR5OttiouLUohWqJr5D4KhJfZQm8PYy5agE1_tl7Gtbn0DOAYccHzfaL6mRLGZ95brwpjUD_imXGCIeOK3eZ0x79kwTehNVVQWTx86zuKg9wkgH8Sk0EZwLdGMkTOBn0RFGzw-aeP1Qn6jsV6MzHJfqtCbw6NIeRIX2tds019gmwjAKpJhJ42rLTYUqMibxEPZuAHDDaYM7Dlnp9GYHAZcitKfME3vUs-fOz_k7T5__X_QXcpVF4aErpCRztt9fuJTpiezOC23IlR3A8PZ1_XODdTMxG8U8NvC6mn0dRLn8AHecrwA
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8IO4EBhgJxANYS-zYSR8Q6mBTx9YKVZu0N2M7DlSUpLSd0P4Uv5HjXDoyxN72VsVOZB-fy-eeG8BLUVWtSyyN0TxQf_-iRmeccmdCyfqRSKss19FYDo_jTyfiZAN-t7kwPqyy1YmVos5K6_8j30ZTjUg9RXjwfv6T-q5R3rvattCo2eLAnf3CK9vy3f5HPN9XjO3tHn0Y0qarALW4qBWVoq7x7j_ILGPGSq7xmZA8N3mOw4gImEy4y5zkWaTRAGfO9o1xzKT9nON3r8Fm7DNae7C5szv-PFn7LZK06t0WcRlTNISiTdNJ5fYSrYWIqQ-J8N68kIYdU1h1DPjXLvxlGC8GbV7w3FYGce823GqQLBnUrHcHNlxxF66PGl_9PRhPypkjZU5ckfk0rxlyOvnh4_8m4wFBgEHKglg9922PFmdk5vR31G1kWpC6uvTU4u8cGbZOrrwPx1dC5wfQK8rCPQISJq4fZjrSIk9ja5mJpeWR0BoBhmNJEkDUElLZprS577AxU9UVJ5WqJr5C4quK-CoM4M36nXld2OPS2Tv-fNYzfVHu6kG5-KoaGVcmD3NhcpMaiTiPh8ZIhwBauNDpHHFSAK_96SqvOnB5VjcZELhJX4RLDaTgEuFUIgLY6sxEkbfd4ZY_VKNylupcQAJ4sR72b_owusKVpzjHl4eUSDUZwMOandZb4lxGKer7AJIOo3X23B0ppt-qguSJj_FJowDetix5vqz_0_Tx5bt4DjeGR6NDdbg_PngCN1klOIwytgW91eLUPUUwuDLPGgkk8OWqhf4Pi31odQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6hIlVcEG8CBYyExAGsJnbsJMelsCqPrlBFpd4s27HLiiVZbbcH_j1j50FTHhK3KLaVeDzj-ayZ-QzwQkTWusLSHN0DDecvanTNKXcmlazKRBmrXI8W8vAk_3AqTi9V8cds9yEk2dU0BJamZru_rn1n4qXcP8edV-Q0pBeEyFhK8dB-PQ-uL4Rr5cEYRyjwU0OpzB_HTdxRZO3_fW--5JyuJk5eiZ5GpzS_BTd7NElm3fLfhmuuuQO7R328_C4sjtuVI60nrqlDqdUKtY18Dzl4x4sZQSdP2oZYvQ5XD21-kJXT33B_IcuGdAzPS4vPHpWmK3C8Byfzd18ODml_gwK1uABbKkXHZ484hzHLmLGSa3wnJPfGe2xG9MNkwV3tJK8zjWCjdrYyxjFTVp7fh52mbdxDIGnhqrTWmRa-zK1lJpeWZ0JrdPKOFUUC2SBIZXt68XDLxUrFY0YpVSd8hcJXUfgqTeDVOGbdkWv8s_ebsD5jz0CMHV-0mzPV25kyPvXCeFMaiViLp8ZIhyBWuNRpj1glgZdhdVUwX_w9q_sqBJxkIMJSMym4REhTiAT2Jj3R7Oy0edAP1Zv9uQpyFlWJGDaB52NzGBlS2RrXXmCfQNEoUWoygQedOo1T4lxmJe65CRQTRZvMedrSLL9GUvAi5NmUWQKvB5X89Vt_l-mj_-v-DHY_v52rT-8XHx_DDRbtiFHG9mBnu7lwTxCfbc3TaII_AbJ9LXc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+endothelial+microRNA+155+on+capillary+leakage+in+systemic+inflammation&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Etzrodt%2C+Valerie&rft.au=Idowu%2C+Temitayo+O.&rft.au=Schenk%2C+Heiko&rft.au=Seeliger%2C+Benjamin&rft.date=2021-02-22&rft.issn=1364-8535&rft.eissn=1364-8535&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs13054-021-03500-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13054_021_03500_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon